Startups
Companies from across the globe provide information on agreements and pipeline updates.
Century’s iPSCs, which are stem cells that can be generated from adult stem cells, have unlimited self-renewing capacity, the company said, which enables multiple rounds of cellular engineering.
Biotech and pharma companies tap new members of executive leadership teams and boards.
Cambridge, Mass.-based Vaxess Technologies is inching closer to developing a bandage-like product that will be able to administer vaccines and other therapeutics through the skin.
Martine Rothblatt cofounded satellite radio company Sirius XM in 1990 but has since moved into biotech.
Encoded said its approach to gene therapy will address key limitations of current gene therapy technology and unlock new treatment opportunities.
The company will focus on chemoproteomics, which it calls a way of interrogating proteins in living systems. This allows them to identify potential new binding targets on proteins, which will allow the development of small-molecule drugs.
Comet has set up shop in Kendall Square with about 10 employees. The company has plans to expand to at least double that amount over the next year as it moves from the preclinical phase to the clinical phase.
The companies will combine their research expertise to develop BGB-3245, an investigational, oral, selective small molecule inhibitor of monomer and dimer forms of activating B-RAF mutations including V600 BRAF mutations, non-V600 B-RAF mutations, and RAF fusions.
Probiodrug AG, announced that with entry into the commercial register Stendal the Company has now officially changed its name to Vivoryon Therapeutics AG as of June 11, 2019.
PRESS RELEASES